Skip to main content
. 2024 Oct 21;23:217. doi: 10.1186/s12939-024-02262-9

Table 2.

Registered anticancer biosimilars in Morocco and cost-comparison with the brand-name drugs

Brand-name drug Cost Biosimilar Cost Economy
Rituximab (Rituxan/MabThera;Roche) 9735 MAD (500 mg) Zelva 9735 MAD 0%

Bevacizumab

(Avastin; Roche)

11,582 MAD Ypeva 9333 MAD 11%

Trastuzumab IV 150 mg

(Herceptin; Roche)

4261 MAD Hertraz 150 mg 3317 MAD 22%
Herzuma 440 mg 3316 MAD 22%
Trazuva 440 mg 3317 MAD 22%